Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
- Conditions
- Interventions
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 384
- Registration Number
- NCT03223753
- Locations
- 🇺🇸
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
🇺🇸New York Medical College, Valhalla, New York, United States
🇺🇸Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
- Conditions
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 224
- Registration Number
- NCT03206450
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Sinai Hospital of Baltimore, Baltimore, Maryland, United States
🇺🇸Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2023-12-28
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 301
- Registration Number
- NCT03204916
- Locations
- 🇺🇸
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States
🇺🇸NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States
🇺🇸Saint Mary's Regional Medical Center, Reno, Nevada, United States
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Conditions
- Interventions
- Procedure: Autologous Hematopoietic Stem Cell TransplantationProcedure: Biospecimen CollectionProcedure: Bone Marrow Aspiration and BiopsyDrug: CarboplatinDrug: BusulfanDrug: CisplatinProcedure: Computed TomographyDrug: CyclophosphamideDrug: Dexrazoxane HydrochlorideBiological: DinutuximabDrug: Doxorubicin HydrochlorideProcedure: EchocardiographyDrug: Etoposide PhosphateRadiation: External Beam Radiation TherapyRadiation: Iobenguane I-123Drug: IsotretinoinRadiation: Iobenguane I-131Procedure: Multigated Acquisition ScanDrug: LorlatinibDrug: Melphalan HydrochlorideProcedure: Positron Emission TomographyProcedure: Magnetic Resonance ImagingBiological: SargramostimProcedure: Therapeutic Conventional SurgeryDrug: ThiotepaDrug: Topotecan HydrochlorideDrug: Vincristine Sulfate
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 724
- Registration Number
- NCT03126916
- Locations
- 🇺🇸
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
🇺🇸Henry Ford Health Saint John Hospital, Detroit, Michigan, United States
🇺🇸Children's Hospital of Alabama, Birmingham, Alabama, United States
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Conditions
- Stage I Ovarian ChoriocarcinomaStage I Testicular Embryonal Carcinoma AJCC v6 and v7Stage I Testicular Seminoma AJCC v6 and v7Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7Stage II Testicular Yolk Sac Tumor AJCC v6 and v7Stage III Ovarian ChoriocarcinomaStage III Testicular Choriocarcinoma AJCC v6 and v7Stage III Testicular Yolk Sac Tumor AJCC v6 and v7Stage IV Ovarian ChoriocarcinomaStage IV Ovarian Embryonal Carcinoma AJCC v6 and v7
- Interventions
- Procedure: BiopsyOther: Best PracticeProcedure: Biospecimen CollectionBiological: Bleomycin SulfateDrug: CarboplatinDrug: CisplatinProcedure: Computed TomographyDrug: EtoposideProcedure: Magnetic Resonance ImagingOther: Pharmacogenomic StudyProcedure: Pulmonary Function TestOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 2097
- Registration Number
- NCT03067181
- Locations
- 🇺🇸
Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States
🇺🇸Mercy San Juan Medical Center, Carmichael, California, United States
🇺🇸Kaiser Permanente Downey Medical Center, Downey, California, United States
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
- First Posted Date
- 2017-02-20
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 376
- Registration Number
- NCT03057626
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸Sinai Hospital of Baltimore, Baltimore, Maryland, United States
🇺🇸Medical City Dallas Hospital, Dallas, Texas, United States
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
- First Posted Date
- 2017-02-17
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 173
- Registration Number
- NCT03057054
- Locations
- 🇺🇸
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States
🇺🇸University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
🇺🇸Children's Hospital of Alabama, Birmingham, Alabama, United States
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Conditions
- Interventions
- Drug: Calaspargase PegolProcedure: Allogeneic Hematopoietic Stem Cell TransplantationDrug: CyclophosphamideDrug: CytarabineDrug: Daunorubicin HydrochlorideDrug: DexamethasoneDrug: Dexrazoxane HydrochlorideDrug: DoxorubicinDrug: EtoposideBiological: FilgrastimDrug: IfosfamideDrug: Imatinib MesylateDrug: MethotrexateOther: Laboratory Biomarker AnalysisDrug: Leucovorin CalciumDrug: PegaspargaseDrug: PrednisoloneDrug: MercaptopurineDrug: MethylprednisoloneOther: Questionnaire AdministrationDrug: Therapeutic HydrocortisoneDrug: ThioguanineDrug: Vincristine Sulfate
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 475
- Registration Number
- NCT03007147
- Locations
- 🇺🇸
Henry Ford Health Saint John Hospital, Detroit, Michigan, United States
🇺🇸Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸USA Health Strada Patient Care Center, Mobile, Alabama, United States
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
- Conditions
- Interventions
- Drug: Asparaginase Erwinia chrysanthemiProcedure: Biospecimen CollectionProcedure: Bone Marrow Aspiration and BiopsyDrug: Calaspargase PegolDrug: CyclophosphamideDrug: CytarabineProcedure: Diagnostic ImagingBiological: Inotuzumab OzogamicinDrug: Leucovorin CalciumProcedure: Lumbar PunctureDrug: MethotrexateDrug: PegaspargaseDrug: Vincristine
- First Posted Date
- 2016-12-05
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 80
- Registration Number
- NCT02981628
- Locations
- 🇺🇸
Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸Providence Alaska Medical Center, Anchorage, Alaska, United States
🇺🇸Banner Children's at Desert, Mesa, Arizona, United States
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 33
- Registration Number
- NCT02975882
- Locations
- 🇺🇸
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
🇺🇸Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States